DOI QR코드

DOI QR Code

Associations of Probiotics with Vitamin D and Leptin Receptors and their Effects on Colon Cancer

  • Ranji, Peyman (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, International Branch of Tabriz University of Medical sciences (Aras)) ;
  • Akbarzadeh, Abolfazl (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences) ;
  • Rahmati-Yamchi, Mohammad (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences)
  • Published : 2015.05.18

Abstract

Colorectal cancer (CRC) is one of most common causes of cancer-related death worldwide. Recent studies have suggested that microbial and environmental factors including diet and lifestyle can impact on colon cancer development. Vitamin D deficiency and dysfunction of vitamin D receptor (VDR) also correlate with colon cancer. Moreover, leptin, a 16-kDa polypeptide, participates in the regulation of food intake and is associated with other environmental factors affecting colon cancer through the leptin receptor. Altered levels of serum leptin and patterns of expression of its receptor (LPR) may be observed in human colon tumours. Furthermore, the collected data from in vitro and in vivo studies have indicated that consuming probiotic non-pathogenic lactic acid bacteria have beneficial effects on colon cancer. Probiotics, inflammation and vitamin D/VDR have been correlated with leptin and its receptor and are also with colon cancer. Thus, in this paper, we review recent progress on the roles of probiotic, vitamin D/VDR and leptin/LPR in inflammation and colon cancer.

Keywords

Colon cancer;leptin;leptin receptor;probiotic;vitamin D;vitamin D receptor

References

  1. Urbanska AM, Bhathena J, Martoni C, et al (2009). Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc (Min/+) mice. Dig Dis Sci, 54, 264-73. https://doi.org/10.1007/s10620-008-0363-2
  2. Wada K, Tanaka H, Maeda K, et al (2009). Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncology reports, 22, 1021.
  3. Weiss ST (2011). Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy Clin Immunol Pract, 127, 1128. https://doi.org/10.1016/j.jaci.2011.02.025
  4. Wu S, Liao AP, Xia Y, et al (2010). Vitamin D receptor negatively regulates bacterial-stimulated NF-${\kappa}B$ activity in intestine. Am J Pathol, 177, 686-97. https://doi.org/10.2353/ajpath.2010.090998
  5. Wu S, Sun J (2011). Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery Med, 11, 325.
  6. Yoon S, Wu S, Zhang Y-g, et al (2011). Probiotic regulation of vitamin D receptor in intestinal inflammation. Gastroenterology, 140, S-19.
  7. Yoon SS, Sun J (2011). Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterology research and practice, 2011.
  8. Yu K, Yang J, Jiang Y, et al (2014). Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev, 15, 4801-7. https://doi.org/10.7314/APJCP.2014.15.12.4801
  9. Zheng W, Wong KE, Zhang Z, et al (2012). Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer, 130, 10-9. https://doi.org/10.1002/ijc.25992
  10. Zhu Y, Michelle Luo T, Jobin C, et al (2011). Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett, 309, 119-27. https://doi.org/10.1016/j.canlet.2011.06.004
  11. Zinser GM, Suckow M, Welsh J (2005). Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol, 97, 153-64. https://doi.org/10.1016/j.jsbmb.2005.06.024
  12. Ahima RS, Osei SY (2004). Leptin signaling. Physiology & Behavior, 81, 223-41. https://doi.org/10.1016/j.physbeh.2004.02.014
  13. Akinci MB, Sendur M, Aksoy S, et al (2014). Serum 25-hydroxy Vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors. Asian Pac J Cancer Prev: APJCP, 15, 3377. https://doi.org/10.7314/APJCP.2014.15.8.3377
  14. Al-Jashamy K, Murad A, Zeehaida M, et al (2010). Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev, 11, 1765-8.
  15. Aloulou N, Bastuji-Garin S, Le Gouvello S, et al (2008). Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res, 68, 9413-22. https://doi.org/10.1158/0008-5472.CAN-08-0909
  16. Aparicio T, Kotelevets L, Tsocas A, et al (2005). Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in ApcMin/+ mice. Gut, 54, 1136-45. https://doi.org/10.1136/gut.2004.060533
  17. Bartucci M, Svensson S, Ricci-Vitiani L, et al (2010). Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. Endocrine-related Cancer, 17, 823-33. https://doi.org/10.1677/ERC-10-0083
  18. Basseri RJ, Basseri B, Papadakis KA (2011). Dysplasia and cancer in inflammatory bowel disease. https://doi.org/10.1586/egh.10.77
  19. Bolukbas FF, Kilic H, Bolukbas C, et al (2004). Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer, 4, 29. https://doi.org/10.1186/1471-2407-4-29
  20. Bouillon R, Carmeliet G, Verlinden L, et al (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews, 29, 726-76. https://doi.org/10.1210/er.2008-0004
  21. Abreu M, Kantorovich V, Vasiliauskas E, et al (2004). Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density. Gut, 53, 1129-36. https://doi.org/10.1136/gut.2003.036657
  22. Abreu MT, Peek RM, Jr. (2014). Gastrointestinal malignancy and the microbiome. Gastroenterology, 146, 1534-46. https://doi.org/10.1053/j.gastro.2014.01.001
  23. Carlberg C, Dunlop TW (2006). The impact of chromatin organization of vitamin D target genes. Anticancer Research, 26, 2637-45.
  24. Collins AT, Berry PA, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer research, 65, 10946-51. https://doi.org/10.1158/0008-5472.CAN-05-2018
  25. Davis CD, Milner JA (2009). Gastrointestinal microflora, food components and colon cancer prevention. J Nutritional Biochemistry, 20, 743-52. https://doi.org/10.1016/j.jnutbio.2009.06.001
  26. Drew JE (2012). Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proceedings of the Nutrition Society, 71, 175-80. https://doi.org/10.1017/S0029665111003259
  27. Endo H, Hosono K, Uchiyama T, et al (2011). Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut, 2010, 235754.
  28. Fearon ER (2011). Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease, 6, 479-507. https://doi.org/10.1146/annurev-pathol-011110-130235
  29. Gianotti L, Morelli L, Galbiati F, et al (2010). A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World journal of gastroenterology: WJG, 16, 167. https://doi.org/10.3748/wjg.v16.i2.167
  30. Guarner F, Malagelada J-R (2003). Gut flora in health and disease. The Lancet, 361, 512-9. https://doi.org/10.1016/S0140-6736(03)12489-0
  31. Hardwick JC, Van Den Brink GR, Offerhaus G, et al (2001). Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90. https://doi.org/10.1053/gast.2001.25490
  32. Hoda M, Keely S, Bertelsen L, et al (2007). Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg, 94, 346-54. https://doi.org/10.1002/bjs.5530
  33. Holick MF (2010). Vitamin D and health: evolution, biologic functions, and recommended dietary intakes for vitamin D. In 'Vitamin D', Eds Springer, 3-33
  34. Huang P, Chandra V, Rastinejad F (2010). Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol, 72, 247-72. https://doi.org/10.1146/annurev-physiol-021909-135917
  35. Hui L, Desen W, Zhizhong P, et al (2011). Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochem Biophysics, 60, 241-4. https://doi.org/10.1007/s12013-010-9145-5
  36. Ishikawa H, Akedo I, Otani T, et al (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer, 116, 762-7. https://doi.org/10.1002/ijc.21115
  37. Ishikawa M, Kitayama J, Nagawa H (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res, 10, 4325-31. https://doi.org/10.1158/1078-0432.CCR-03-0749
  38. Isono M, Inoue R, Kamida T, et al (2003). Significance of leptin expression in invasive potential of pituitary adenomas. Clin Neurol Neurosurgery, 105, 111-6. https://doi.org/10.1016/S0303-8467(02)00129-4
  39. Joshi RK, Lee S-A (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405. https://doi.org/10.7314/APJCP.2014.15.1.397
  40. Kailasapathy K, Chin J (2000). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell Biology, 78, 80-8. https://doi.org/10.1046/j.1440-1711.2000.00886.x
  41. Kaji R, Kiyoshima-Shibata J, Nagaoka M, et al (2010). Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol, 184, 3505-13. https://doi.org/10.4049/jimmunol.0901569
  42. Kotnis A, Sarin R, Mulherkar R (2005). Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J Biosciences, 30, 93-102. https://doi.org/10.1007/BF02705154
  43. Kumar M, Nagpal R, Verma V, et al (2013). Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev, 71, 23-34. https://doi.org/10.1111/j.1753-4887.2012.00542.x
  44. Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Disease, 24, 275-81. https://doi.org/10.1007/s00384-008-0605-y
  45. Lagishetty V, Misharin AV, Liu NQ, et al (2010). Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology, 151, 2423-32. https://doi.org/10.1210/en.2010-0089
  46. Lee NK, Park JS, Park E, et al (2007). Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Letters in Applied Microbiol, 44, 274-8. https://doi.org/10.1111/j.1472-765X.2006.02078.x
  47. Leung K-C (2004). Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction. DNA and Cell Biology, 23, 463-74. https://doi.org/10.1089/1044549041562285
  48. Lu R, Wu S, Xia Y, et al (2012). The vitamin D receptor, inflammatory bowel diseases, and colon cancer. Current Colorectal Cancer Reports, 8, 57-65. https://doi.org/10.1007/s11888-011-0114-1
  49. Matilainen JM, Rasanen A, Gynther P, et al (2010). The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1${\alpha}$, 25 (OH) 2 D 3 target genes. J Steroid Biochemistry and Molecular Biology, 121, 142-5. https://doi.org/10.1016/j.jsbmb.2010.03.020
  50. Matsunuma A, Horiuchi N (2007). Leptin attenuates gene expression for renal 25-hydroxyvitamin D 3-1${\alpha}$-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys, 463, 118-27. https://doi.org/10.1016/j.abb.2007.02.031
  51. McEwan IJ 2009. Nuclear receptors: one big family, Springer.
  52. Mencarelli A, Distrutti E, Renga B, et al (2011). Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One, 6, 22978. https://doi.org/10.1371/journal.pone.0022978
  53. Menendez C, Lage M, Peino R, et al (2001). Retinoic acid and vitamin D (3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol, 170, 425-31. https://doi.org/10.1677/joe.0.1700425
  54. Mirza NN, McCloud JM, Cheetham MJ (2009). Clostridium septicum sepsis and colorectal cancer-a reminder. World J Surg Oncol, 7, 73. https://doi.org/10.1186/1477-7819-7-73
  55. Mu H-J, Zou J, Xie P, et al (2014). Association of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinoma. Asian Pac J Cancer Prev, 15, 4211-5. https://doi.org/10.7314/APJCP.2014.15.10.4211
  56. O'mahony L, Feeney M, O'halloran S, et al (2001). Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alimentary Pharmacology & Therapeutics, 15, 1219-25. https://doi.org/10.1046/j.1365-2036.2001.01027.x
  57. Palmer HG, Gonzalez-Sancho JM, Espada J, et al (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol, 154, 369-87. https://doi.org/10.1083/jcb.200102028
  58. Pendas-Franco N, Aguilera O, Pereira F, et al (2008). Vitamin D and Wnt/${\beta}$-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Research, 28, 2613-23.
  59. Pereira F, Larriba MJ, Munoz A (2012). Vitamin D and colon cancer. Endocrine-related cancer, 19, 51-71. https://doi.org/10.1530/ERC-11-0388
  60. Ramagopalan SV, Heger A, Berlanga AJ, et al (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research, 20, 1352-60. https://doi.org/10.1101/gr.107920.110
  61. Rasool S, Kadla SA, Khan T, et al (2013). Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. Asian Pac J Cancer Prev, 14, 5833-7. https://doi.org/10.7314/APJCP.2013.14.10.5833
  62. Reiff C, Delday M, Rucklidge G, et al (2009). Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL# 3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases, 15, 1721-36. https://doi.org/10.1002/ibd.20999
  63. Reya T, Clevers H (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843-50. https://doi.org/10.1038/nature03319
  64. Salageanu A (2010). Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life, 3, 416.
  65. Samuel S, Sitrin MD (2008). Vitamin D's role in cell proliferation and differentiation. Nutrition reviews, 66, 116-24. https://doi.org/10.1111/j.1753-4887.2008.00094.x
  66. Schauber J, Dorschner RA, Coda AB, et al (2007). Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. The J Clin Invest, 117, 803-11. https://doi.org/10.1172/JCI30142
  67. Sentongo TA, Semaeo EJ, Stettler N, et al (2002). Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr, 76, 1077-81.
  68. Shamsuzzaman AS, Winnicki M, Wolk R, et al (2004). Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation, 109, 2181-5. https://doi.org/10.1161/01.CIR.0000127960.28627.75
  69. Slattery M, Ballard-Barbash R, Edwards S, et al (2003). Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control, 14, 75-84. https://doi.org/10.1023/A:1022545017867
  70. Slattery ML, Curtin K, Sweeney C, et al (2007). Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer, 120, 656-63. https://doi.org/10.1002/ijc.22342
  71. Slattery ML, Wolff RK, Herrick J, et al (2008). Leptin and leptin receptor genotypes and colon cancer: Gene-gene and gene-lifestyle interactions. Int J Cancer, 122, 1611-7.
  72. Sonoda J, Pei L, Evans RM (2008). Nuclear receptors: decoding metabolic disease. FEBS letters, 582, 2-9. https://doi.org/10.1016/j.febslet.2007.11.016
  73. Stubbins RE, Hakeem A, Nunez NP (2012). Using components of the vitamin D pathway to prevent and treat colon cancer. Nutr Rev, 70, 721-9. https://doi.org/10.1111/j.1753-4887.2012.00522.x
  74. Sun J (2010). Vitamin D and mucosal immune function. Curr Opinion Gastroenterology, 26, 591. https://doi.org/10.1097/MOG.0b013e32833d4b9f
  75. Suzuki T, Franchi L, Toma C, et al (2007). Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS pathogens, 3, 111. https://doi.org/10.1371/journal.ppat.0030111
  76. Thorne J, Campbell MJ (2008). The vitamin D receptor in cancer. Proc Nutrition Society, 67, 115-27. https://doi.org/10.1017/S0029665108006964
  77. Tutino V, Notarnicola M, Guerra V, et al (2011). Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res, 31, 3381-3.
  78. Uchiyama T, Takahashi H, Endo H, et al (2011). Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. Int J Oncol, 39, 935.

Cited by

  1. Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer pp.1867-1314, 2018, https://doi.org/10.1007/s12602-018-9478-8
  2. More Protection of Lactobacillus acidophilus Than Bifidobacterium bifidum Probiotics on Azoxymethane-Induced Mouse Colon Cancer pp.1867-1314, 2018, https://doi.org/10.1007/s12602-018-9425-8